Study guide
11.1 Food Allergy, Anaphylaxis & Emergency Planning
PNCB Certified Pediatric Nurse Practitioner - Primary Care CPNP-PC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application & Testing Window 1.3 Content Outline, Domains & Clinical Categories
2 Well-Child Care & Anticipatory Guidance
2.1 Bright Futures Periodicity & Well-Child Structure 2.2 Anticipatory Guidance: Newborn Through Toddler 2.3 Anticipatory Guidance: Preschool Through Young Adult
3 Immunization Counseling
3.1 Immunization Principles, Indications & Schedules 3.2 Contraindications, Precautions & Adverse Effects 3.3 Vaccine Hesitancy & Risks of Non-Adherence
4 Injury Prevention, Safety & Illness Prevention
4.1 Age-Appropriate Injury Prevention & Safety 4.2 Environmental Exposure, Violence & Disaster Preparedness 4.3 Illness Prevention & Early Warning Signs
5 Social, Behavioral & Mental Health Promotion
5.1 Social Media, Sleep, School & Lifestyle Counseling 5.2 Substance Use, Grief, Trauma & Sexual Health Education 5.3 Oral Health, Fluoride & Nutrition Promotion
6 Growth, Development & Physical Examination
6.1 Growth Parameters & Growth Charts 6.2 Developmental Surveillance & Red Flags 6.3 Complete vs Focused Physical Examination
7 History, Diagnostics & Clinical Decision Making
7.1 HPI, Review of Systems & Social Histories 7.2 Point-of-Care, Laboratory & Imaging Tests 7.3 Differentials, Data Synthesis & Diagnosis
8 Screening and Assessment Tools
8.1 Developmental & Behavioral Screening Tools 8.2 Mental Health & Substance Screening Tools 8.3 SDOH & Disease-Specific Screening
9 Developmental, Behavioral & Mental Health Conditions
9.1 ADHD Assessment & Management 9.2 Autism Spectrum & Developmental Delay 9.3 Anxiety, Depression & Suicide Risk
10 Dermatology
10.1 Atopic Dermatitis, Contact Dermatitis & Inflammatory Skin Disease 10.2 Infectious Dermatoses, Infestations & Warts 10.3 Acne, Vascular Lesions, Birthmarks & Hair-Nail Disorders
11 Allergy, Immunology & Otolaryngology
11.1 Food Allergy, Anaphylaxis & Emergency Planning 11.2 Allergic Rhinitis, Urticaria & Immunodeficiency Clues 11.3 Otitis, Pharyngitis, Sinusitis & Hearing
12 Gastroenterology
12.1 GER, Vomiting & Infant Feeding Intolerance 12.2 Constipation, Encopresis & Chronic Abdominal Pain 12.3 Acute Diarrhea, Celiac Disease & IBD Red Flags
13 Infectious Diseases
13.1 Fever Without Source, Serious Bacterial Infection & Kawasaki 13.2 Common Viral & Bacterial Primary Care Infections 13.3 Influenza, COVID-19 & Vaccine-Preventable Disease
14 Pulmonology
14.1 Asthma Diagnosis, Control & Action Plans 14.2 Bronchiolitis, Croup & Community-Acquired Pneumonia 14.3 Chronic Cough, OSA & Respiratory Red Flags
15 Musculoskeletal, Orthopedics & Pain
15.1 Limp, Developmental Hip Dysplasia & Nursemaid's Elbow 15.2 Scoliosis, Sports Injuries & Overuse Syndromes 15.3 Pediatric Pain Assessment & Primary Care Pain Management
16 Nutrition, Endocrinology & Genetics
16.1 Failure to Thrive, Undernutrition & Pediatric Obesity 16.2 Diabetes, Thyroid Disease & Pubertal Disorders 16.3 Genetics, Dysmorphology & Newborn Screening Follow-Up
17 Sexual & Reproductive Health
17.1 Puberty, Menstrual Disorders & Gynecologic Primary Care 17.2 Contraception, Confidential Care & Pregnancy 17.3 STI Screening, Prevention & Sexual Health Counseling
18 Cardiology, Neurology & Ophthalmology
18.1 Heart Murmurs, Hypertension & Syncope 18.2 Seizures, Headache & Concussion 18.3 Vision Screening, Strabismus, Red Eye & Fluorescein
19 Urology, Nephrology, Hematology & Rheumatology
19.1 UTI, Enuresis, Hydronephrosis & Acute Scrotum 19.2 Anemia, Lead, Sickle Cell Trait & Bleeding Clues 19.3 Juvenile Idiopathic Arthritis, HSP & Autoimmune Red Flags
20 Child Maltreatment, Environmental Health & Office Procedures
20.1 Child Maltreatment Recognition, Reporting & Documentation 20.2 Environmental Health, Lead, Poisoning & Toxicology 20.3 Primary Care Procedures & Life-Threatening First Response
21 Management: Therapeutics, Referral & Care Coordination
21.1 Caregiver Counseling, Non-Pharmacologic Care & Shared Decision-Making 21.2 Pediatric Prescribing, OTC Therapy & Adherence 21.3 Referral, CPS Collaboration, Care Coordination, Transition & Follow-Up
22 Leadership, Ethics & Practice Management
22.1 Evidence-Based Practice, Quality Improvement & Advocacy 22.2 Scope of Practice, HIPAA, Informed Consent, Culture & Ethics 22.3 Documentation, Coding, Access to Care & Telehealth
11.1 Food Allergy, Anaphylaxis & Emergency Planning
Key Takeaways Explain This Topic AI
IgE-mediated food allergy is rapid (minutes to about 2 hours) and can be anaphylaxis; FPIAP is a well infant with bloody, mucus stools; FPIES is delayed profuse vomiting and lethargy — IgE tests do not diagnose the non-IgE syndromes.
The usual pediatric food allergens are milk, egg, peanut, tree nut, soy, wheat, fish, and shellfish; an unselected food-IgE panel is not a diagnosis.
NIAID/LEAP: introduce peanut around 6 months in the general population; for severe eczema and/or egg allergy, consider testing or allergy referral and introduce as early as 4–6 months if the infant is not allergic — delaying peanut is not prevention.
Anaphylaxis treatment is intramuscular epinephrine in the anterolateral thigh first, then EMS; oral antihistamine is not first-line. Teach the autoinjector, prescribe two devices, and issue a written emergency action plan.
Biphasic anaphylaxis can recur hours later without re-exposure. Refer allergy for anaphylaxis, FPIES, high-risk infant peanut decisions, multiple food allergies, and unclear diagnoses.
Last updated: August 2026
Allergy and immunology is clinical category #3 by exam volume on the PNCB CPNP-PC outline; otolaryngology is #4 . This section is the allergy slice that kills children when the first drug is wrong: food allergy and anaphylaxis . Domain II wants IgE-mediated disease separated from non-IgE gut syndromes. Domain III wants an epinephrine-first emergency plan, autoinjector teaching, and a written action plan — not an antihistamine-first delay.
Exam trap — oral antihistamine is not first-line anaphylaxis care. Diphenhydramine, a second-generation H1 blocker, or a corticosteroid does not reverse airway edema, shock, or bronchospasm. Intramuscular epinephrine in the anterolateral thigh is first. Antihistamines may later reduce itch and hives. They never replace epinephrine.
IgE-mediated versus non-IgE food disease
IgE-mediated food allergy is a rapid, reproducible reaction after a specific food: urticaria, angioedema, vomiting, cough, wheeze, stridor, hypotension, or a combination. Onset is usually minutes to 2 hours . Skin-prick testing and food-specific IgE can support a matching history; they do not diagnose allergy by themselves. A positive test without a clinical reaction is sensitization . The oral food challenge, performed where anaphylaxis can be treated, remains the confirmation step when history and tests disagree.
Non-IgE disease is delayed and gut-predominant. Serum IgE and skin tests are typically negative and should not be used as a grocery-list fishing expedition.
Entity Typical timing Clinical picture First CPNP-PC move
IgE food allergy Minutes to ~2 hours Hives, swelling, respiratory or cardiovascular signs, vomiting Avoid the food; epinephrine autoinjector if anaphylaxis risk; allergy referral
FPIAP (food protein-induced allergic proctocolitis) Hours to days of ongoing exposure Specks or streaks of blood and mucus in stool ; the infant is usually thriving Empiric cow's-milk elimination (often soy as well); no epinephrine plan solely for FPIAP
FPIES (food protein-induced enterocolitis syndrome) 1–4 hours after a feeding Profuse vomiting, lethargy, pallor, diarrhea, dehydration; may look septic Emergency fluids ; do not treat isolated FPIES as an IgE problem that skin testing will diagnose; allergy referral
FPIAP is the breastfed or formula-fed young infant with bloody stools who is otherwise well. The usual trial is maternal dietary cow's-milk elimination (add soy restriction if milk restriction fails) or a switch to an extensively hydrolyzed formula. Amino-acid formula is for hydrolysate failure or poor growth. Most infants outgrow FPIAP in the first year. Do not label this infant "milk anaphylaxis" and do not order a 30-food IgE panel.
Acute FPIES is a different emergency: repetitive vomiting, limpness, and pallor 1–4 hours after milk, soy, rice, or oat. Shock can occur. Management is hemodynamic support (saline boluses; ondansetron in acute care). Epinephrine is used if the picture overlaps anaphylaxis or the child is hypotensive and the mechanism is unclear — FPIES itself is not an IgE mast-cell event. Chronic FPIES from ongoing exposure presents as diarrhea, poor weight gain, and irritability. Diagnosis is clinical.
Clinic vignette. A thriving 8-week-old has flecks of blood in the stool and a normal abdominal exam. This is FPIAP until proven otherwise — not an autoinjector and not a diagnosis of IgE milk allergy.
The common pediatric food allergens
Counsel the foods that actually cause most U.S. pediatric reactions.
- Food Pattern the CPNP-PC uses
- Cow's milk Common in infants; IgE and non-IgE both occur; many IgE milk allergies resolve in childhood
Egg Common; baked-egg tolerance sometimes precedes whole-egg tolerance — do not assume this without specialist guidance
- Peanut Often persistent; prevention is early introduction , not delay
- Tree nuts Often persistent; each nut is a separate question; do not ban every nut without data
- Soy More often outgrown; co-restriction with milk is a FPIAP tactic, not an automatic IgE rule
- Wheat Distinguish IgE wheat allergy from celiac disease (autoimmune, gluten, not an epinephrine disease)
- Fish Often persistent; species may differ
- Shellfish Often persistent; more often presents later than milk or egg
Sesame is increasingly recognized and is labeled under U.S. law. A "nut-free" classroom is not automatically sesame-free. Do not diagnose celiac disease as wheat anaphylaxis, and do not treat IgE wheat allergy with a celiac "trace gluten" lecture.
Avoid unselected food-IgE panels in chronic abdominal pain, isolated allergic rhinitis, or a well child. False-positive tests create needless elimination diets, growth failure, and family fear.
Early peanut introduction (NIAID / LEAP)
The LEAP trial showed that high-risk infants who ate peanut regularly developed less peanut allergy than infants who avoided peanut. NIAID's addendum guideline translated that into primary-care timing. Complementary feeding starts when the infant is developmentally ready; peanut is not delayed as a prevention strategy.
Infant risk NIAID timing CPNP-PC action
Severe eczema and/or egg allergy (high risk) Introduce peanut as early as 4–6 months after other complementary foods, after consideration of testing or allergy referral Do not tell this family to wait until age 1 "to be safe." Consider peanut-specific IgE or referral before the first home taste when eczema is severe or egg allergy is already diagnosed
Mild-to-moderate eczema Introduce peanut around 6 months Age-appropriate peanut (thinned peanut butter, dissolvable puffs) — never whole peanuts
No eczema, no food allergy Introduce peanut with other complementary foods around 6 months , according to family diet Do not delay peanut past the complementary-food window as prevention
Whole peanuts and thick spoonfuls of peanut butter are choking hazards. Mix a small amount of peanut butter into puree, or use dissolvable peanut puffs. Once peanut is tolerated, keep it in the diet regularly; a one-time taste is not the LEAP protocol.
Prevention trap: delaying peanut, egg, or milk in a low-risk infant to "prevent allergy" is outdated and is the opposite of current peanut-prevention evidence.
Anaphylaxis: epinephrine first, then the plan
Anaphylaxis is a serious systemic allergic reaction that is rapid in onset and may cause death. In children it is often food-triggered. Recognize skin plus respiratory , skin plus cardiovascular , or hypotension after a known allergen even without hives. Isolated hives without other systems is urticaria, not automatically anaphylaxis — but do not withhold epinephrine if you are clinically unsure and the child is progressing.
First drug, first site, first next step
Epinephrine IM into the anterolateral thigh (vastus lateralis), through clothing if needed.
Use the autoinjector the family has, or 0.01 mg/kg of 1 mg/mL (1:1000) epinephrine IM. Usual pediatric community max is 0.3 mg per dose (some acute-care protocols allow 0.5 mg in adolescents).
Typical autoinjector teaching: 0.15 mg for most young children in the 15–30 kg range (0.1 mg devices exist for smaller infants); 0.3 mg at ≥30 kg . Teach the device the family actually carries and match current product labeling for weight.
Call EMS. Observation belongs where biphasic reaction and airway compromise can be treated — not in the family car while waiting to see if an antihistamine works.
A second IM dose may be given after 5–15 minutes if symptoms persist or worsen. Prescribe two devices.
Position: recumbent with legs raised if hypotensive; sitting forward if in respiratory distress; do not make a hypotensive child stand or walk.
Not first-line: oral or IM antihistamines, albuterol as monotherapy, systemic corticosteroids as the opening move, subcutaneous epinephrine, or waiting for IV access. Albuterol may help bronchospasm after epinephrine. Steroids are adjuncts and do not abort the acute reaction. H1 antihistamines treat urticaria, not shock.
Autoinjector teaching is a primary-care skill, not an optional handout. Demonstrate the trainer. Name the thigh — not the buttock and not a clothed deltoid as the preferred community site. Teach a second adult. Check expiration dates at well visits. Document a written allergy and anaphylaxis emergency action plan (FARE or equivalent) for home and school, and support a Section 504 plan when food is in the classroom. Children with food anaphylaxis and asthma need extra respect: most food-allergy fatalities involve delayed epinephrine and underlying asthma.
Biphasic reaction is a second wave of anaphylaxis after apparent resolution, without re-exposure, classically hours later (often taught in a 1–8 hour window, sometimes longer). That is why EMS and ED observation exist. It is not a reason to skip the first epinephrine dose; it is a reason not to discharge from the parking lot.
When the CPNP-PC refers to allergy
Refer rather than serial-guessing elimination diets:
- Any anaphylaxis
- IgE-mediated peanut, tree-nut, fish, shellfish, or multiple-food allergy
- High-risk infant (severe eczema and/or egg allergy) needing supervised peanut introduction or testing
- FPIES
- Need for oral food challenge or discussion of oral immunotherapy
- Food allergy plus uncontrolled asthma or repeated community epinephrine use
- Diagnostic uncertainty after a reaction that might have been viral urticaria, not food
Primary care still owns prevention counseling, the first epinephrine prescription after a community reaction, device teaching, the action plan, growth on elimination diets, and not ordering junk panels.
Exam traps
Oral antihistamine as first-line anaphylaxis treatment.
Treating FPIAP as IgE milk anaphylaxis, or treating FPIES as a problem that skin testing will diagnose.
Delaying peanut in a general-population infant until age 1 "to prevent allergy."
Sending a high-risk infant (severe eczema or egg allergy) home to try peanut with no testing or referral thought.
Diagnosing food allergy from a positive IgE panel without a matching history.
Letting the family "watch at home" after community epinephrine.
IgE versus non-IgE, introduce peanut on time, epinephrine in the thigh first, then EMS, two autoinjectors, and a written plan. That is food allergy on this exam.